Clinical trials
Recruiting Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 8 |
| 2024 | 12 |
| 2025 | 14 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 6 |
| Fudan University | 4 |
| Evopoint Biosciences Inc. | 2 |
| Haihe Biopharma Co., Ltd. | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Sun Yat-sen University | 2 |
| The First Affiliated Hospital of Soochow University | 2 |
| Associazione Angela Serra per la ricerca sul cancro | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 57 |
| Lymphoma, T-Cell | 10 |
| Lymphoma, Non-Hodgkin | 9 |
| Lymphoma, T-Cell, Cutaneous | 8 |
| Recurrence | 8 |
| Lymphoma | 7 |
| Immunoblastic Lymphadenopathy | 5 |
| Lymphoma, Large-Cell, Anaplastic | 5 |
| Hematologic Neoplasms | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.